Back to search

Article

ARF6 as a novel activator of HIF-2α in pulmonary arterial hypertension

2023-09-15

Abstract excerpt

<h4>ABSTRACT</h4> ADP-ribosylation factor 6 (ARF6), a GTPase associated with cancer metastasis, is activated in the lung endothelium in pulmonary arterial hypertension (PAH). To identify ARF6-regulated pathways relevant to PAH, we performed a state-of-the-art proteomic analysis of human pulmonary artery endothelial cells (HPAECs) overexpressing the wildtype, constitutively active, fast-cycling and dominant negati...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
d9ed358e-46f9-5bbe-a67b-445467d2c5a0
DOI
10.1101/2023.09.15.557917
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
ARF6 as a novel activator of HIF-2α in pulmonary arterial hypertensionDOI 10.1101/2023.09.15.557917
Select a neighboring publication to make it the new centre.